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Abstract. 
 
A novel genetic selection was used to iden-
tify genes regulating traffic in the yeast endosomal sys-
tem. We took advantage of a temperature-sensitive mu-
tant in 
 
PMA1
 
, encoding the plasma membrane 
ATPase, in which newly synthesized Pma1 is mislocal-
ized to the vacuole via the endosome. Diversion of mu-
tant Pma1 from vacuolar delivery and rerouting to the 
plasma membrane is a major mechanism of suppression 
 
of 
 
pma1
 
ts
 
. 16 independent suppressor of 
 
pma1
 
 (
 
sop
 
) 
mutants were isolated. Identification of the correspond-
ing genes reveals eight that are identical with 
 
VPS
 
 
genes required for delivery of newly synthesized vacu-
olar proteins. A second group of 
 
SOP
 
 genes partici-
pates in vacuolar delivery of mutant Pma1 but is not 
essential for delivery of the vacuolar protease carboxy-
peptidase Y. Because the biosynthetic pathway to the 
vacuole intersects with the endocytic pathway, internal-
ization of a bulk membrane endocytic marker FM 4-64 
was assayed in the 
 
sop
 
 mutants. By this means, defec-
tive endosome-to-vacuole trafficking was revealed in a 
subset of 
 
sop
 
 mutants. Another subset of 
 
sop
 
 mutants 
displays perturbed trafficking between endosome and 
Golgi: impaired pro-
 
a
 
 factor processing in these strains 
was found to be due to defective recycling of the 
 
trans
 
-
Golgi protease Kex2. One of these strains defective in 
Kex2 trafficking carries a mutation in 
 
SOP2
 
, encoding a 
homologue of mammalian synaptojanin (implicated in 
synaptic vesicle endocytosis and recycling). Thus, cell 
surface delivery of mutant Pma1 can occur as a conse-
quence of disturbances at several different sites in the 
endosomal system.
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1. 
 
Abbreviations used in this paper
 
: CPY, carboxypeptidase; IP5P, inositol
5-phosphatase; ORF, open reading frame; 
 
sop
 
, suppressor of 
 
pma1.
 
I
 
n 
 
eukaryotic cells, the unique identity of each mem-
brane-bounded compartment is maintained by proper
targeting and sorting of proteins. Within the secretory
pathway, proteins and lipids move between compartments
via vesicular transport (Palade, 1975). The specificity of
this transport is regulated by selective packaging of con-
tent into vesicles, specific interaction of receptors on trans-
port vesicles and target membranes, and selective mem-
brane and protein retrieval and retention (Rothman and
Wieland, 1996; Schekman and Orci, 1996). In recent years,
many components of the vesicular transport machinery, as
well as regulatory molecules that confer specificity and di-
rectionality, have been identified and characterized.
The endosomal membrane system is a branch of the
secretory pathway in which biosynthetic traffic intersects
with endocytic traffic from the cell surface. Among the
best-characterized processes in the endosomal/lysosomal
pathway is the mechanism by which newly synthesized sol-
uble hydrolases are delivered to the lysosome (Kornfeld
and Mellman, 1989). In mammalian cells, proteins tagged
with a mannose-6-phosphate sorting signal interact with
mannose-6-phosphate receptors in the Golgi complex. The
interaction leads to sorting away from secreted proteins
and delivery to endosomes (Kornfeld and Mellman, 1989).
In yeast, 
 
.
 
40 
 
VPS
 
 genes encode proteins required for
proper trafficking from the Golgi to the vacuole (Roth-
man and Stevens, 1986; Robinson et al., 1988). The hall-
mark of 
 
vps
 
 mutants is abnormal delivery of vacuolar en-
zyme precursors, such as procarboxypeptidase Y, to the
cell surface. As in mammalian cells, there is a sorting re-
ceptor, encoded by 
 
VPS10
 
, whose recognition of a signal
within carboxypeptidase Y (CPY)
 
1
 
 and other soluble hy-
drolases in the late Golgi compartment is required for
proper delivery via endosomes to the vacuole (Vida et al.,
1993; Marcusson et al., 1994; Cooper and Stevens, 1996).
Vps10 and other late Golgi membrane proteins, e.g., Kex2,
are thought to maintain their localization by cycling be-
tween the Golgi and endosome compartments in a manner
controlled by signals in their cytoplasmic tails (Cooper and
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Bussey, 1992; Wilcox et al., 1992; Nothwehr et al., 1993;
Cereghino et al., 1995; Cooper and Stevens, 1996).
Targeting of lysosomal membrane proteins in mamma-
lian cells is mediated by sorting motifs in the cytoplasmic
tails (Hunziker and Geuze, 1996). In yeast, by contrast, the
question of whether delivery of vacuolar membrane pro-
teins is mediated by sorting signals or whether vacuolar
membrane protein traffic occurs by default remains unre-
solved (Stack and Emr, 1993; Nothwehr and Stevens,
1994). Our understanding of the biosynthetic pathway to
the vacuole in yeast is complicated by multiple vesicle–
mediated routes (Piper, R., N. Bryant, and T.H. Stevens.
1996. 
 
Mol. Biol. Cell.
 
 7:322a; Cowles et al., 1997). Further-
more, it has recently been shown that some misfolded pro-
teins are targeted to the vacuole via a biosynthetic route
(Hong et al., 1996).
The general organization of the endocytic pathway is
well established (Gruenberg and Maxfield, 1995). Extra-
cellular molecules and plasma membrane proteins are in-
ternalized and move to early endosomes, where some pro-
teins may recycle back to the cell surface. Other internalized
proteins move to late endosomes and lysosomes, where
they may be degraded. The set of proteins implicated in
endosomal/vacuolar transport is expanding (Gruenberg
and Maxfield, 1995). In addition, there is growing evidence
that phosphoinositides play a critical role in regulating
membrane traffic in the endosomal/vacuolar pathway (De
Camilli et al., 1996). Nevertheless, it is still unclear what
the precise mechanisms by which these molecules regulate
transport through the endocytic pathway are, and contro-
versy remains about the structure and organization of en-
dosomes. Further complexity is provided by evidence for
more than one endocytic pathway (Sandvig and van
Deurs, 1994).
The approach we have taken to investigate molecular
aspects of the endosomal/lysosomal pathway is to study a
targeting-defective mutant in 
 
PMA1
 
, encoding the plasma
membrane ATPase. In wild-type cells, newly synthesized
Pma1 is delivered to the plasma membrane via the secre-
tory pathway (Chang and Slayman, 1991). Upon arrival at
the cell surface, Pma1 is quite stable with a half-life of 
 
z
 
11 h
(Benito et al., 1991). By contrast, targeting-defective mu-
tant Pma1 is delivered to the vacuole for degradation with-
out ever arriving at the plasma membrane (Chang and
Fink, 1995). The mutant is temperature sensitive; the cells
undergo growth arrest after shifting to the restrictive tem-
perature as the essential ATPase activity preexisting at the
cell surface becomes limiting (Chang and Fink, 1995). At
present, the molecular basis for transport of mutant Pma1
to the vacuolar pathway is not understood. However, we
found previously that mutant Pma1 is enzymatically ac-
tive, and multicopy suppression of temperature-sensitive
 
pma1
 
 occurs by rerouting mutant Pma1 to the plasma mem-
brane (Chang and Fink, 1995). This observation suggested
that it might be possible to isolate mutants that affect
membrane traffic in the endosomal pathway by selecting
suppressors of temperature-sensitive growth of 
 
pma1.
 
In this paper, we report isolation of 16 suppressor of
 
pma1
 
 (
 
sop
 
) mutants that divert newly synthesized mutant
Pma1 from delivery to the vacuole. Identification of the
corresponding 
 
SOP
 
 genes reveals a group identical to a
subset of 
 
VPS
 
 genes required for delivery to the vacuole
 
and also reveals additional novel regulators of protein
traffic. Strikingly, the 
 
sop
 
 mutants display defects in traffic
from endosome to vacuole and/or between endosome and
Golgi. Our data indicate that mutant Pma1 is delivered to
the cell surface as a consequence of disparate defects in the
endosomal system. These findings have important implica-
tions for protein trafficking in the endosomal pathway.
 
Materials and Methods
 
Strains and Media
 
Standard yeast media and genetic manipulations were as described (Sher-
man et al., 1986). Strains used in this study are listed in Table I. All strains
are isogenic with L3852. 
 
sop pma1-7
 
 mutants (WLY strains in Table I)
were generated by transformation of ACY7 with a mutagenized genomic
library (Burns et al., 1994). 
 
PMA1 sop
 
 strains used in this study were
made by crossing 
 
sop pma1
 
 mutants with L5488. A collection of 42 
 
vps
 
mutants was obtained from Bruce Horazdovsky (University of Texas,
Dallas, TX) for complementation analysis with CPY-secreting 
 
sop
 
 mu-
tants. ACY33 (
 
vps27-
 
D
 
1::LEU2
 
) was generated by transformation of
L3852 with pKJH2 (Piper et al., 1995). ACY70 (
 
vps27-123
 
) was generated
by pop-in, pop-out gene replacement in ACY7 using pRCP20 (Piper et al.,
1995). 
 
vps1::LEU2
 
 (ACX58-3C) was generated by transformation of
ACX 28 (Mat 
 
a
 
/
 
a
 
 
 
his3
 
D
 
2
 
/
 
his3
 
D
 
2 lys2
 
D
 
201
 
/
 
lys2
 
D
 
201 leu2-3,112
 
/
 
leu2-3,112
ura3-52
 
/
 
ura3-52 ade2
 
/
 
ade2 pma1-7
 
/
 
PMA1
 
) with the disruption construct
pCKR3A (Rothman et al., 1990). pKJH2, pRCP20, and pCKR3A were
obtained from Tom Stevens (University of Oregon, Eugene, OR). Yeast
transformations were performed by the lithium acetate method (Gietz et
al., 1992).
 
Genetic Selection
 
pma1-7
 
 (ACY7) cells were transformed with each of 14 independent pools
of a mutagenized genomic library containing random 
 
lacZ
 
 and 
 
LEU2
 
 in-
sertions (Burns et al., 1994). Leu
 
1
 
 transformants (
 
z
 
139,000) were plated
at 37
 
8
 
C to select for suppressors of temperature-sensitive growth. 63
strains that grew at 37
 
8
 
C were crossed with WLX2-2A, and the diploid
was subjected to tetrad analysis to determine whether suppression of
 
pma1
 
ts
 
 was linked to a single 
 
LEU2
 
 insertion. Sequence analysis of ge-
nomic DNA adjacent to the insertion was undertaken as described (Burns
et al., 1994). Briefly, 
 
sop
 
 cells were transformed with PvuI-cleaved YIp5.
Genomic DNA was prepared from transformants, cleaved with NsiI, and
ligated. Sequencing of plasmid DNA was carried out using the dideoxy
chain termination method using Sequenase (United States Biochemical,
Cleveland, OH). Sequences were analyzed using BLAST (Altschul et al.,
1990).
 
Indirect Immunofluorescence and FM 4-64 Endocytosis
 
Immunofluorescent localization of Pma1 was done essentially as de-
scribed (Rose et al., 1990). Briefly, mid-log cultures were harvested, resus-
pended in 0.1 M K phosphate, pH 6.5, with 4.4% formaldehyde, and incu-
bated for 2 h at room temperature. Cells were spheroplasted with
oxalyticase (Enzogenetics, Corvallis, OR). For Pma1 staining, cells were
permeabilized with methanol and acetone before incubation overnight
with affinity-purified rabbit anti-Pma1 antibody. For double staining of
Pma1 and vacuolar H
 
1
 
-ATPase, cells were permeabilized with SDS, as
described (Roberts et al., 1991), followed by incubation with rabbit anti-
Pma1 and mouse monoclonal antibody against the 60-kD subunit of the
V-ATPase (Molecular Probes, Inc., Eugene, OR). Primary antibody stain-
ing was visualized with Cy3- and DTAF-conjugated secondary antibody
(Jackson ImmunoResearch, West Grove, PA).
For FM 4-64 internalization studies, cells were grown to mid-log phase
in YPD. After resuspension in fresh YPD at 20 OD
 
600
 
/ml, 20 
 
m
 
M FM 4-64
was added for 5 min at 30
 
8
 
C. Cells were washed, and incubation continued
at 30
 
8
 
C for 1 h. FM 4-64 fluorescence was observed with rhodamine fluo-
rescence filter sets, as described (Vida and Emr, 1995).
 
Western Blot and Invertase Assay
 
Steady-state levels of Pma1, CPY, and Kex2 were analyzed in cell lysates,
prepared from mid-log cultures by vortexing with glass beads, as de- 
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scribed previously (Chang and Slayman, 1991). Samples were normalized
to lysate protein using the Bradford assay (Bio-Rad Laboratories, Her-
cules, CA). After separation by SDS-PAGE, samples were transferred to
nitrocellulose for Western blot with rabbit antibodies against Pma1, CPY,
or Kex2, and 
 
125
 
I–protein A (Amersham Corp., Arlington Heights, IL).
To study trafficking of mutant invertase–Wbp1 fusion protein, cells
were transformed with pEG1-QK (Gaynor et al., 1994). Invertase activity
was measured as described previously (Goldstein and Lampen, 1975;
Johnson et al., 1987). Briefly, mid-log cultures grown in synthetic com-
plete medium without uracil were harvested, washed with 10 mM sodium
azide, and resuspended in 0.1 M sodium acetate, pH 5.1. Samples were di-
vided for assaying cell surface and intracellular invertase activity. Whole
cells were used to assay cell surface activity. Total intracellular invertase
was measured in samples brought to 1% Triton X-100 and lysed by freeze-
thaw with liquid N
 
2
 
. All strains studied are Suc2
 
1
 
 and were grown in the
presence of 2% glucose. Endogenous invertase activity was measured in
several random 
 
sop
 
 mutants (
 
bsd2
 
, 
 
pep11
 
, and 
 
vps13
 
) bearing vector
alone. Endogenous invertase activity, representing 
 
z
 
13% activity seen in
the presence of pEG1-QK, was subtracted from activity measured in the
presence of the plasmid.
 
CPY and 
 
a
 
 Factor Secretion
 
CPY secretion from cells was detected as described (Roberts et al., 1991).
Strains were replica-plated onto a nitrocellulose filter (Schleicher and
Schuell, Dassel, Germany) and allowed to grow at 30
 
8
 
C. After 
 
z
 
24 h, the
filter was washed with water to remove adsorbed cells. CPY secreted onto
 
the filter was detected by Western blot using rabbit polyclonal anti-CPY
antibody. Immune complexes were visualized by chemiluminescence de-
tection reagents (ECL Western blotting detection system; Amersham
Corp.).
Secretion of 
 
a
 
 factor was detected essentially as described (Wilsbach
and Payne, 1993). Cells were grown to mid-log phase in synthetic com-
plete medium without methionine. Cells were harvested and resuspended
at 0.8 OD
 
600
 
/ml in fresh medium with 1 mg/ml BSA. Expre
 
35
 
S
 
35
 
S (0.5 mCi)
(New England Nuclear, Boston, MA) was added, and incubation contin-
ued for 50 min at room temperature. Medium was separated from cells by
centrifugation at 19,500 
 
g
 
 for 5 min. SDS was added to the medium to 1%,
and samples were boiled. Secreted 
 
a
 
 factor was immunoprecipitated with
anti–
 
a
 
 factor antibody and analyzed by SDS-PAGE (15% gels) and auto-
radiography after treatment of gels with Amplify (Amersham Corp.).
Bioassay for 
 
a
 
 factor secretion was done as described (Sprague, 1991).
Patches of 
 
MAT
 
a
 
 cells were replica-plated onto a thin lawn of 
 
MAT
 
a
 
bar1
 
 cells (LM23-3az; [Marsh, 1992]) on synthetic complete medium. After
1–2 d at 30
 
8
 
C, halos surrounding patches of 
 
a
 
 cells were scored.
 
Results
 
Vacuolar Delivery of Mutant Pma1 via an
Endosomal Intermediate
 
To show that mutant Pma1 is delivered to the vacuole via
 
Table I. Yeast Strains Used in This Study
 
Strains Genotype Source
 
L3852
 
MAT
 
a
 
 his3
 
D
 
200 lys 2
 
D
 
201 leu2-3,112 ura3-52 ade2
 
Fink lab collection, Whitehead Institute
L5488
 
MAT
 
a
 
 lys2
 
D
 
201 leu2-3,112 ura3-52
 
Fink lab collection, Whitehead Institute
ACY7
 
MAT
 
a
 
 his3
 
D
 
200 lys2
 
D
 
201 leu2-3,112 ura3-52 ade2 pma1-7
 
Chang and Fink (1995)
WLX2-2A
 
MAT
 
a
 
 lys2
 
D
 
201 leu2-3,112 ura3-52 pma1-7
 
This study
WLY1
 
MAT
 
a
 
 his3
 
D
 
200 lys2
 
D
 
201 leu2-3,112 ura3-52 ade2 pma1-7 bsd2-
 
D
 
1::LEU2
 
This study
WLY2
 
MAT
 
a
 
 his3
 
D
 
200 lys2
 
D
 
201 leu2-3,112 ura3-52 ade2 pma1-7 vps13-
 
D
 
1::LEU2
 
This study
WLY4
 
MAT
 
a
 
 his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 alg8::LEU2 This study
WLY10 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 sop5::LEU2 This study
WLY12 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 vps36-D1::LEU2 This study
WLY13 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 pep11::LEU2 This study
WLY16 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 vps8::LEU2 This study
WLY19 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 sop6-D1::LEU2 This study
WLY22 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 sop2-D1::LEU2 This study
WLY25 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 vps27-D1::LEU2 This study
WLY29 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 sop4::LEU2 This study
WLY33 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 sop3::LEU2 This study
WLY37 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 mvp1-D1::LEU2 This study
WLY38 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 vps35-D1::LEU2 This study
WLY40 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 vps38-D1::LEU2 This study
WLY57 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 sop1::LEU2 This study
ACX58-3C MATa his2D201 lys2D201 leu2-3,112 ura3-52 ade2 vps1D::LEU This study
WLX3-2A MATa lys2D201 leu2-3,112 ura3-52 ade2 sop2-D1::LEU2 This study
WLX8-1B MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 sop4::LEU2 This study
WLX9-12C MATa lys2D201 leu2-3,112 ura3-52 sop3::LEU2 This study
WLX10-2A MATa lys2D201 leu2-3,112 ura3-52 sop5::LEU2 This study
WLX11-1C MATa lys2D201 leu2-3,112 ura3-52 sop6-D1::LEU2 This study
WLX12-7C MATa lys2D201 leu2-3,112 ura3-52 vps36-D1::LEU2 This study
WLX13-3B MATa his3D200 lys2D201 leu2-3,112 ura3-52 pep11::LEU2 This study
WLX14-10A MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 vps38-D1::LEU2 This study
WLX15-4C MATa his3D200 lys2D201 leu2-3,112 ura3-52 vps13-D1::LEU2 This study
WLX16-1A MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 vps8::LEU2 This study
WLX17-6D MATa lys2D201 leu2-3,112 ura3-52 mvp1-D1::LEU2 This study
WLX18-6D MATa his3D200 lys2D201 leu2-3,112 ura3-52 vps35-D1::LEU2 This study
WLX19-3A MATa his3D200 lys2D201 leu2-3,112 ura3-52 sop1::LEU2 This study
ACY33 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 vps27::LEU2 This study
ACY70 MATa his3D200 lys2D201 leu2-3,112 ura3-52 ade2 pma1-7 vps27-123(ts) This study
BFY106-4D MATa his3-11,15 leu2-3,112 ura3-1 trp1-1 ade2-1oc can1-100 kex2D2::HIS3-A Robert Fuller, University of Michigan, Ann Arbor, MI
LM23-3az MATa bar1 ura3 leu2 his4 trp1 met1 [FUS1-lacZ::URA3] Marsh (1992)The Journal of Cell Biology, Volume 138, 1997 734
an endosomal intermediate, indirect immunofluorescence
was used to localize Pma1, and a marker of the vacuolar
membrane, the 60-kD subunit of the vacuolar H1-ATP-
ase. Fig. 1 shows that in pma1-7 cells, mutant Pma1 ap-
pears coincident with vacuoles, visualized by V-ATPase
staining, and as indentations of the cell surface by Nomar-
ski optics (upper panel). Mutant Pma1 is also seen fre-
quently as one or two spots adjacent to, but distinct from,
Figure 1. Indirect immunofluorescence localization of mutant Pma1 in a prevacuolar compartment. Localization of Pma1 and V-ATP-
ase in pma1-7 and pma1-7 vps27ts cells. Mid-log cultures were harvested, fixed, and spheroplasted. Cells were permeabilized with SDS
before staining with rabbit anti-Pma1 and mouse monoclonal antibody against the 60-kD subunit of V-ATPase, followed by species-spe-
cific CY3- and DTAF-conjugated secondary antibodies. (Upper panel) Mutant Pma1 staining is coincident with V-ATPase staining at
the vacuolar membrane in pma1-7 cells at 308C. In these cells, mutant Pma1 is also seen as spots distinct from the vacuole (arrowheads).
Nomarski optics show vacuoles as indentations. (Lower panel) pma1-7 vps27ts cells were shifted to 378C for 1 h. Both mutant Pma1 and
the 60-kD V-ATPase subunit are accumulated in the prevacuolar compartment.Luo and Chang Novel Genes Involved in Endosomal Traffic 735
the vacuole (arrowheads). These spots have a striking sim-
ilarity to an exaggerated endosomal or prevacuolar com-
partment that appears adjacent to the vacuole in a subset
of vps mutants, categorized as class E vps mutants (Ray-
mond et al., 1992; Davis et al., 1993; Piper et al., 1995). To
obtain further evidence for mutant Pma1 transit through
an endosomal intermediate, a temperature-sensitive allele
of vps27, a class E vps mutant, was introduced into pma1-7
cells. Previous work has shown that proteins from both
biosynthetic and endocytic pathways are rapidly accumu-
lated in a prevacuolar or endosomal compartment upon
shifting vps27ts to 378C (Piper et al., 1995). Mutant Pma1 is
seen predominantly in this prevacuolar compartment when
pma1-7 vps27ts cells are shifted to 378C for 1 h (Fig. 1,
lower panel). In these cells, the 60-kD V-ATPase subunit
is similarly accumulated in the prevacuolar compartment,
in agreement with previous observations (Raymond et al.,
1992). These data suggest that mutant Pma1 traverses an
endosomal compartment en route to the vacuole.
Rerouting of Targeting-defective Pma1 to the Cell 
Surface in sop Mutants
To select mutants that suppress temperature-sensitive
growth of pma1-7, cells were transformed with a mu-
tagenized genomic library containing random insertions of
lacZ and LEU2 (Burns et al., 1994). sop pma1-7 mutants
that grew at 378C were selected. Tetrad analysis of sop
pma1 3 pma1 diploids revealed that growth at 378C of 53/63
sop mutants analyzed segregated 2:2, indicating these mu-
tations represent single genetic loci. Of these, suppression
of temperature-sensitive growth was linked to the LEU2
insertion in 36 strains. All sop pma1 mutants grow at both
30 and 378C, while pma1-7 cells grow at 308C but cannot
grow at 378C. In Fig. 2 A, growth of some representative
sop pma1 mutants is shown along with PMA1 and pma1-7
cells. sop selection resulted in identification of 16 indepen-
dent genes.
In pma1-7 cells, steady-state Pma1 protein is reduced
because, even at the permissive temperature, a fraction of
newly synthesized Pma1 is delivered to the vacuole; stabi-
lization of mutant Pma1 protein reflects escape from deg-
radation in the vacuole (Chang and Fink, 1995). To deter-
mine whether mutant Pma1 protein is stabilized in sop
mutants, steady-state Pma1 protein was measured by
Western blot in PMA1, pma1-7, and the sixteen sop pma1-7
strains (Fig. 2 B). Fig. 2 B shows mutant Pma1 is increased
to differing degrees in sop mutants (compare with pma1-7;
Fig. 2 B, arrow). 
Growth arrest of pma1-7 at 378C cannot be prevented
merely by inhibiting vacuolar proteolytic activity (upon
disruption of PEP4, encoding proteinase A [Jones, 1991]),
but requires that an increased fraction of Pma1 arrives at
Figure 2. Suppression of temperature-sensitive growth and stabi-
lization of mutant Pma1 protein in sop mutants. (A) Growth at 30
and 378C on plates (synthetic complete medium). PMA1 (L5488)
cells grow at 30 and 378C, whereas pma1-7 (ACY7) cells grow at
308C but do not grow at 378C. sop/vps pma1 cells (WLY2,
WLY12, WLY22, WLY 25, WLY33, WLY40) grow at 30 and
378C. (B) Western blot showing steady-state levels of Pma1 pro-
tein. Lysate was prepared from PMA1, pma1-7, and sop pma1-7
cells exponentially growing at 308C. Samples were normalized to
lysate protein. Pma1 protein was detected using anti-Pma1 anti-
body and 125I–protein A followed by autoradiography. Bar graph
shows quantitation of Pma1 levels in wild-type and sop pma1-7
mutants by densitometric scanning of the autoradiogram. Pma1
levels are normalized to that of pma1-7 (arrow), set arbitrarily to
1.0. Western blot is representative of three to five independent
measurements in which the standard deviation of the mean is on
average 26%.The Journal of Cell Biology, Volume 138, 1997 736Luo and Chang Novel Genes Involved in Endosomal Traffic 737
the cell surface (Chang and Fink, 1995). Therefore, sup-
pression of growth arrest and Pma1 stabilization by sop
mutants suggests rerouting to the plasma membrane. To
confirm this idea, localization of mutant Pma1 was exam-
ined by indirect immunofluorescence in wild-type, pma1-7,
and sop pma1 cells. In wild-type cells, Pma1 staining is
seen over the surface and around the cell perimeter, char-
acteristic of plasma membrane localization (Fig. 3, upper
panel). In pma1-7 cells, mutant Pma1 staining appears co-
incident with vacuoles and also as perivacuolar spots, re-
flecting mislocalization to the endosomal/vacuolar path-
way. In representative sop pma1 cells, intracellular staining
of mutant Pma1 largely disappears; rim staining is more
apparent, indicating a redistribution of Pma1 to the plasma
membrane (Fig. 3, lower three panels).
A Subset of sop Mutants Are vps Mutants
The identity of the 16 disrupted sop genes was determined
by cloning and sequencing of genomic DNA immediately
adjacent to the insertion (Burns et al., 1994). Database
searches revealed that several sop mutants represent in-
sertions in previously identified genes. Two of these are
BSD2, previously isolated as a mutant suppressor of su-
peroxide dismutase deletion (Liu and Culotta, 1994), and
ALG8, encoding a potential glucosyltransferase (Stagljar
et al., 1994). Both proteins are localized to the ER, al-
though the mechanism of suppression of pma1ts is unclear
at present. Five other sop mutants are identical with vps
mutants defective in vacuolar protein sorting, supporting
the idea that a major mechanism of pma1ts suppression is
by changing protein traffic. We found sop mutants identi-
cal with pep11 (Jones, 1977), mvp1 (Ekena and Stevens,
1995), vps35 (Paravicini et al., 1992), vps27 (Piper et al.,
1995), and vps8. Although pep11 was originally isolated as
a mutant with reduced vacuolar protease activity (Jones,
1977), we find that it is defective for vacuolar protein sort-
ing and secretes CPY (Fig. 4 A).
CPY secretion assay was performed on the 16 sop mu-
tants to determine whether we had isolated additional vps
mutants whose DNA sequences were not in the database
(Fig. 4 A). In this way, we discovered that three additional
sop mutants secrete CPY. By complementation of these
three mutants with a collection of 42 vps mutants (ob-
tained from B. Horazdovsky), we determined that our se-
lection had resulted in identification of VPS13, VPS36,
and VPS38, which had not been previously cloned and se-
quenced. Table II lists the database accession numbers for
these three as well as some of the other SOP genes. The
predicted protein sequences of VPS13, VPS36, and VPS38
were then analyzed by BLAST searches, revealing novel
proteins of 3144, 566, and 439 amino acids, respectively.
No similarity was detected between these proteins and
other protein sequences in the database. Hydropathy anal-
ysis showed that the three proteins have no obvious
Figure 3. Mutant Pma1 is rerouted to the cell surface in sop mutants as seen by indirect immunofluorescence. Cells exponentially grow-
ing at 308C were fixed, permeabilized, and stained with rabbit anti-Pma1 antibody followed by CY3-conjugated secondary antibody.
PMA1 (L5488) cells show cell surface Pma1 localization (top panel) while pma1-7 cells (ACY7) display striking intracellular staining
(second panel). Suppressed pma1-7 cells display a predominant plasma membrane distribution of mutant Pma1 (lower three panels). sop
pma1 strains shown are WLY2, WLY22, and WLY25.
Figure 4. A subset of sop mutants is defective for vacuolar pro-
tein sorting. (A) Western blot detecting secretion of CPY. Cells
were overlayed with nitrocellulose overnight. Secreted CPY ad-
sorbed to the membrane was visualized with rabbit anti-CPY fol-
lowed by horseradish peroxidase–conjugated secondary antibody
and chemiluminescence detection reagents. PMA1 (L5488) and
pma1-7 (ACY7) are shown as non–CPY-secreting controls.
vps1D (ACX58-3C), which secretes the vast majority of newly
synthesized pro-CPY (Raymond et al., 1992), is included as a pos-
itive control. (B) Western blot showing intracellular CPY. Pro-
tein lysate was prepared from exponentially growing cells, as de-
scribed in Methods. Samples were normalized to lysate protein.
CPY was detected as described above. Strains assayed (left to
right) are: ACY7, L3852, WLX17-6D, WLX13-3B, WLX18-6D,
ACY33, WLX12-7C, WLX15-4C, WLX16-1A, and WLX14-10A.
Mature CPY associated with vps cells is substantially decreased
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amino-terminal signal sequence or membrane-spanning
domains. Analysis by BLAST and COILS2.1 (Lupas et al.,
1991) indicated that a region of Vps38 has some probabil-
ity to form a coiled coil structure (not shown).
Previous work classifying vps mutants on the basis of
vacuolar morphology is of importance to understanding
the significance of identifying a subset of vps mutants as
suppressors of pma1ts (Raymond et al., 1992). Most of the
sop/vps mutants fall into class A (mvp1, pep11, vps35,
vps13,  vps38, and vps8), which have vacuolar morphology
similar to wild-type cells. In addition, two mutants, vps27
and vps36, fall into class E, in which a prevacuolar com-
partment or late endosome accumulates (Raymond et al.,
1992; Piper et al., 1995; Rieder et al., 1996).
In agreement with increased CPY secretion from vps/
sop mutants (Fig. 4 A), cell-associated mature CPY in most
of these cells is decreased by comparison with wild-type
and pma1-7 cells (Fig. 4 B). Mature CPY is the predomi-
nant form found in wild-type and pma1-7 cells. More ma-
ture CPY is seen in lysates from the class E mutants vps27
and vps36, consistent with accumulation and processing of
newly synthesized CPY in the proteolytically active pre-
vacuolar compartment (Cereghino et al., 1995; Piper et al.,
1995).
Several sop Mutants Increase Surface Expression of a 
Vacuole-directed Membrane Marker
vps/sop mutants cause diversion of CPY and mutant Pma1
to the cell surface, suggesting a general role for these
genes in regulating traffic of vacuole-bound proteins. We
wanted to test whether these and other sop mutants can
divert a second vacuole-directed membrane protein to the
cell surface. To do this, we used a chimeric membrane pro-
tein that was shown previously to travel to the vacuole
without arrival at the plasma membrane (Gaynor et al.,
1994). The construct is a fusion of invertase with the trans-
membrane domain and cytoplasmic tail of Wbp1, an ER
membrane protein, with a Q-K substitution in the dilysine
retrieval motif. Cells were transformed with a centromeric
plasmid bearing the chimeric construct. The presence of
the fusion protein at the plasma membrane was quanti-
tated by assaying surface invertase activity in intact cells in
comparison to total invertase activity in permeabilized
cells. Expression of the chimera is high since it is regulated
by the PRC1 (encoding CPY) promoter (Gaynor et al.,
1994).
Table III shows that cell surface expression of the inver-
tase–Wbp1–Q-K chimera is increased in all vps/sop mu-
tants. Highest cell surface expression (.40% of total) is
seen in vps8, and cell surface expression in the other vps/
sop mutants ranges from 20–30% of total. Therefore, this
group of sop/vps mutants causes rerouting of two mem-
brane proteins from the vacuole to the plasma membrane.
By contrast, non-vps sop mutants increase cell surface mu-
tant Pma1 (Fig. 2) but do not significantly increase plasma
membrane expression of the chimeric membrane marker.
Endosome-to-Vacuole Traffic Is Delayed in Several
vps/sop Mutants
Previous characterization of vps27, a class E vps mutant,
suggests a model for suppression of pma1ts. vps27 is char-
acterized by delayed traffic from the endosome to the vac-
uole as well as from the endosome back to the Golgi
(Piper et al., 1995); this phenotype appears to be a general
characteristic of the class (Davis et al., 1993; Cereghino et
al., 1995). The finding that two class E vps mutants, vps27
 
Table II. Identification of New and vps Genes by sop Selection
Gene Insertion position Remarks/reference Accession number
VPS36 (2) ND; 932/1700 New gene
ID by complementation
566 amino acids
gb U20162_7.cds YLR417w
VPS13 (4) 3797; 7694; 8961; ND/9434 New gene
ID by complementation
3144 amino acids
Redding et al. (1996)
emb Z73145 YLL040c
VPS38 (2) 241; ND/1319 New gene
ID by complementation
439 amino acids
gb U19103_2.cds YLR360w
VPS8 (1) 382/3531 1176 amino acids gb U44026_1.cds YAL002w
PEP11 (1) 386/846 282 amino acids SwissProt P38759 YHR012w
VPS35 (2) 2555; 249/2813 Paravicini et al. (1992)
MVP1 (2) 1417; 33/1535 Ekena and Stevens (1995)
VPS27 (2) 84/1868 Piper et al. (1995)
BSD2 (8) 88;87; 810; 44; 563; 677; 253; 122/966 Liu and Culotta (1994)
ALG8 (1) 1192/1733 Stagljar et al. (1994)
SOP2 (3) 1120;120; 669/3323 New gene
1,107 amino acids
homology to synaptojanin
embX94335_26.cds
SC130kbXV; YOR3231w
The number of times each sop gene was selected out of 63 sop mutants picked is indicated in parentheses. Insertion site indicates the codon at which lacZ is inserted and the total
number of codons in the gene. In some cases, insertion site information is not available (ND) because identification of the sop mutation was made by complementation only. DNA
sequencing and database searching revealed the sop mutations that had been previously identified, cloned, and sequenced in other genetic screens. All other sop mutants are inser-
tions within novel open reading frames. Complementation analysis of CYP-secreting sop mutants with a complete set of vps mutants led to identification of vps13, vps36, and
vps38. Accession and locus designations are indicated for these vps. Molecular information on five non-vps sop mutants (sop1, sop3-6) is not presented here because further
phenotypic characterization is in progress.Luo and Chang Novel Genes Involved in Endosomal Traffic 739
and vps36, suppress pma1ts suggests cell surface delivery of
mutant Pma1 may occur as a consequence of a block or
delay in endosome-to-vacuole and/or endosome-to-Golgi
traffic. To confirm that the efficiency of delivery from en-
dosome to vacuole is reduced in vps36, we examined the
endocytic pathway by following internalization of the fluo-
rescent lipophilic styryl dye FM 4-64. FM 4-64 serves as a
marker for bulk plasma membrane internalization; trans-
port of the endocytic tracer from the cell surface to the
vacuolar membrane occurs in a time-, temperature-, and
energy-dependent manner (Vida and Emr, 1995). Cells
were labeled with FM 4-64 for 5 min. The cells were then
washed, and incubation continued for 1 h in fresh medium.
Immediately after staining, internalized FM 4-64 is seen as
cytoplasmic punctate staining in wild-type as well as vps36
cells (not shown and Vida and Emr [1995]). Subsequently,
cytoplasmic punctate staining in wild-type cells disappears
concomitant with appearance of staining of vacuolar mem-
brane. By 60 min after labeling, staining is seen predomi-
nantly at the vacuolar membrane in wild-type cells (Fig.
5). At this time in vps36 cells, there is some FM 4-64 dye at
the vacuolar membrane; however, dye also accumulates as
a large bright spot next to the vacuole (Fig. 5). This stain-
ing is similar to that seen in the endosomal/prevacuolar
compartment of vps27 cells (Vida and Emr, 1995).
Using the dye uptake assay, we examined the other sop
mutants. While none are defective in internalization of FM
4-64 (not shown), a subset of sop mutants displays defects
in transport to the vacuole after internalization. Strikingly,
we observed that FM 4-64 stains the vacuolar membrane
by 1 h of internalization in vps38 and vps13 cells, but it is
also accumulated in an endocytic intermediate compart-
ment, seen as a bright spot next to the vacuole. The com-
partment is similar, although smaller than the prevacuolar
compartment accumulated in class E vps cells. Thus, there
is a delay in endocytic delivery to the vacuole in vps38 and
vps13. Moreover, perturbation of endocytic traffic was
also observed in vps8 (Fig. 5). By contrast with prevacu-
olar accumulation, a fraction of FM 4-64 accumulates as
punctate cytoplasmic staining in vps8; this cytoplasmic ac-
cumulation fails to advance in the endocytic pathway, even
60 min after internalization. Thus, distinct endocytic de-
fects are apparent among this subset of sop mutants.
Several sop Mutants Display Defective
Pro–a factor Processing
Since endosome-to-vacuole traffic appears perturbed in a
subset of sop mutants, we tested whether other endosome-
mediated traffic pathways are also affected. It has been es-
tablished that retention of membrane proteins in the late
Golgi, i.e., Kex2, Kex1, and dipeptidyl aminopeptidase A
is mediated by signals in their cytoplasmic domains that
dictate recycling between Golgi and endosome compart-
ments (Cooper and Bussey, 1992; Wilcox et al., 1992;
Nothwehr et al., 1993). Mutations in the protein transport
machinery affecting exit from the Golgi and/or retrieval
from the endosome result in mislocalization of late Golgi
membrane proteins (Seeger and Payne, 1992; Wilsbach
and Payne, 1993; Cereghino et al., 1995). One conse-
quence of such mislocalization is a maturation defect for a
factor precursor (Fuller et al., 1988; Payne and Schekman,
1989). Therefore, we assayed for production of biologi-
cally active a factor in sop cells. MATa cells were replica-
plated onto a lawn of MATa bar1 cells which undergo
growth arrest in response to the concentration of mature a
factor secreted from each MATa cell. Wild-type MATa
cells are surrounded by a large halo of growth inhibition
(Fig. 6 A). Cells deleted of KEX2, required for proteolytic
processing of pro–a factor (Fuller et al., 1988; Payne and
Schekman, 1989), produce no halo of growth inhibition.
Most of the vps/sop mutants are surrounded by halos that
are smaller to varying degrees than that of wild-type cells,
indicating diminished secretion of mature, biologically ac-
tive a factor. The smallest halos were observed surround-
ing vps8 and vps36. Of the vps/sop subset, only vps13 and
vps38 cells produce halos of growth inhibition comparable
with wild-type cells. Halos surrounding sop1-6 mutants are
also comparable to that of wild-type cells.
One of the first steps in proteolytic processing of pro–a
factor is Kex2-mediated removal of the pro-peptide (Ful-
ler et al., 1988; Payne and Schekman, 1989). To determine
whether unprocessed pro–a factor is secreted by MATa
sop mutants, cells were radiolabeled with [35S]cysteine and
Table III. Quantitation of Cell Surface Expression of a 
Vacuolar Membrane Marker in sop Mutants
Strain Percent activity at surface
pma1-7 9.7
sop1 pma1-7 10.7
sop2 pma1-7 7.6
sop3 pma1-7 17.0
sop4 pma1-7 6.8
sop5 pma1-7 6.8
sop6 pma1-7 8.5
mvp1 pma1-7 20.0
pep11 pma1-7 30.9
vps35 pma1-7 33.1
vps27 pma1-7 18.1
vps36 pma1-7 29.3
vps13 pma1-7 27.2
vps8 pma1-7 41.7
vps38 pma1-7 29.5
PMA1 8.5
PMA1 (L3852), pma1-7 (ACY7), and sop pma1 cells (Table I) were transformed with
pEG1-QK bearing a mutant WBP1-SUC2 fusion (Gaynor et al., 1994) and assayed af-
ter growth to mid-log phase in synthetic complete medium minus uracil (2% glucose).
Intracellular and cell surface invertase activity were measured by assaying detergent-
permeabilized and intact cells, respectively (Johnson et al., 1987). Invertase activity is
expressed as nmol glucose released per min per OD600. Since all the strains are Suc21,
endogenous invertase activity (in the absence of the fusion protein) was subtracted
from activity measured in the presence of pEG1-QK. Under the glucose-repressing
conditions of the experiment (2% glucose), endogenous intracellular invertase activity
represented an average of 13.3% of total activity (n 5 39) measured in the presence of
the fusion protein. Endogenous invertase activity was measured in bsd2, vps36, and
pep11 in the presence of vector alone; activity was similar in all strains. Cell surface
invertase activity is expressed as a percent of total and represents the average of two to
four independent experiments per strain. All measurements were performed in quadru-
plicate. A diagram of the Wbp1–invertase fusion with the Q-K substitution in the cyto-
plasmic carboxy terminus is drawn as described previously (Gaynor et al., 1994).The Journal of Cell Biology, Volume 138, 1997 740
[35S]methionine. a Factor–containing forms were then im-
munoprecipitated from the medium for analysis by SDS-
PAGE and fluorography. Fig. 6 B shows that a factor se-
creted by wild-type MATa cells is exclusively the processed,
mature 3.5-kDa form (lower arrow). By contrast, several
sop mutants secrete precursor a factor of z125-kD in ad-
dition to the processed form (Fig. 6 B), indicating defec-
tive proteolytic processing by Kex2p. Strikingly, secretion
of pro–a factor was detected in two non-vps sop mutants,
sop2 and sop6 (Fig. 6 B). Most of the vps/sop mutants also
secrete unprocessed a factor, although secretion of pro–a
factor is low from vps8, vps13, and vps38. vps36 cells se-
crete the highest fraction of pro–a factor, consistent with
production of a small halo (Fig. 6 A), and an approxi-
mately sixfold decrease in mating efficiency by compari-
son with wild-type cells (not shown).
Steady-State Kex2 Levels in sop Mutants
Kex2p mislocalization has previously been observed in
class E mutants (Cereghino et al., 1995). Since the prevac-
uolar compartment of class E mutants contains proteolytic
activity (Cereghino et al., 1995; Piper et al., 1995), defec-
tive recycling between late Golgi and endosome results in
failure of Kex2 to escape from PEP4-dependent degrada-
tion in the prevacuolar compartment. Consequently, there
is a reduction in steady-state Kex2p levels. To examine
whether degradation of Kex2 occurs in sop mutants,
steady-state levels of Kex2 were measured by Western
blot. As expected, Kex2 levels are reduced in the class E
mutants vps27 and vps36 as compared with that of wild-
type cells (Fig. 7, arrow). Strikingly, Kex2 levels are also
significantly decreased in mvp1, pep11, and vps35 cells, as
Figure 5. Visualization of endocytosis in sop mutants by FM 4-64 staining. Exponentially growing wild-type cells and sop mutants were
stained with FM 4-64 for 5 min at 308C, washed, and incubated in fresh YPD for 1 h before visualization and photography. Vacuolar
membrane staining is seen in wild-type cells (L3852). In vps36 (WLX12-7C), a class E vps mutant, FM 4-64 dye is accumulated in a pre-
vacuolar compartment. A similar accumulation of dye as a spot near the vacuole is seen in vps38 (WLX14-10A) and vps13 (WLX15-
4C). Bright punctate staining in the cytoplasm remains in vps8 (WLX16-1A) after 1 h of chase.Luo and Chang Novel Genes Involved in Endosomal Traffic 741
well as the non-vps sop mutants, sop2 and sop6 (Fig. 7,
compare with Kex2 in wild-type cells). Steady-state Kex2
levels are similar in sop and wild-type cells upon deletion
of PEP4 (not shown), indicating that Fig. 7 reflects differ-
ences in Kex2 degradation. A comparison of the sop mu-
tants reveals that, in general, mutants with less Kex2 se-
crete more pro–a factor, and less pro–a factor secretion is
seen in mutants with more Kex2 (compare Fig. 7 with Fig.
6 B). Among the class A vps/sop mutants, loss of Kex2 is
not observed in mutants that have endosome-to-vacuole
traffic defects (vps13, vps38, and vps8; Fig. 5). Intriguingly,
in vps8 there is no reduction in steady-state Kex2 levels
even though there is a severe defect in production of bio-
logically active a factor (Fig. 6 A).
SOP2 Encodes a Homologue of Synaptojanin, a Member 
of the Inositol 5-Phosphatase Family
Secretion of pro–a factor as well as reduced steady-state
Kex2 in sop2 and sop6 mutants suggests defective traffic
between Golgi and endosome. Molecular characterization
of the non-VPS SOP genes is in progress. However, analy-
sis of the DNA sequence of SOP2 revealed that the open
reading frame of 3,323 nucleotides predicts a 1,107-amino
acid polypeptide. Database search showed that Sop2 pro-
tein has high sequence similarity with synaptojanin, a
nerve terminal protein with inositol 5-phosphatase (IP5P)
activity (McPherson et al., 1994). Synaptojanin is associ-
ated with dynamin and amphiphysin and has been pro-
posed to play a role in synaptic vesicle endocytosis and re-
cycling. Sop2 also has sequence similarity with two other
yeast open reading frames (ORFs) in the database that
were not picked up as suppressors of pma1. An alignment
of these proteins is shown in Fig. 8. All four proteins
contain two conserved motifs, GDXN(Y/F)R and P(S/A)
W(C/T)DRI (Fig. 8, asterisks); these conserved residues
have been proposed to function directly in catalysis for
IP5Pases (Majerus, 1996). Evidently, Sop2, like synaptoja-
nin, plays a role in the endosomal pathway. Whether the
two yeast homologues have overlapping function with
Sop2 remains to be established.
Discussion
Selection for sop Mutants
A targeting-defective pma1 mutant has provided the
Figure 6. Production of biologically active a factor and secretion
of unprocessed pro–a factor by sop mutants. (A) Secretion of bi-
ologically active mature a factor was detected by halo assay.
Wild-type (L3852) and sop mutants were patched on plates with
synthetic complete medium and allowed to grow overnight. The
MATa strains were then replica-plated onto a lawn of MATa
bar1 cells (LM23-3AZ; Table I). After 1–2 d, halos surrounding
patches of a cells were scored. No halo is observed surrounding
kex2D cells (BFY106-4D), which is included as a control. sop mu-
tant strains are: WLX19-3A, WLX3-2A, WLX9-12C, WLX8-1B,
WLX10-2A, WLX11-1C, WLX12-7C, WLX13-3B, WLX14-10A,
WLX15-4C, WLX16-1A, WLX17-6D, WLX18-6D, and ACY33.
(B) Secretion of pro–a factor by wild-type and sop cells. Expo-
nentially growing cells (0.4 OD600/0.5 ml) were labeled at room
temperature with Expre35S35S for 50 min. Culture medium was
collected, adjusted to 1% SDS, and boiled. Secreted a factor was
immunoprecipitated from the medium, and analyzed by SDS-
PAGE (15% polyacrylamide gel) and fluorography. The lower
arrowhead indicates mature a factor, a 3.5-kD peptide, and the
upper arrowhead indicates precursor a factor with a molecular
mass of z125 kD. Wild-type cells secrete mature a factor exclu-
sively. A subset of sop cells secrete both unprocessed and mature
a factor. Strains assayed are: WLX19-3A, WLX3-2A, WLX9-
12C, WLX8-1B, WLX10-2A, WLX11-1C, L3852, WLX17-6D,
WLX13-3B, WLX18-6D, ACY33, WLX12-7C, WLX15-4C,
WLX16-1A, and WLX14-10A.The Journal of Cell Biology, Volume 138, 1997 742
means to select mutants affecting the endosomal/vacuolar
pathway. Previously, multicopy suppression of targeting-
defective pma1 resulted in identification of YPT7 (Chang,
A., unpublished result), a member of the small GTPase
family regulating endosome-to-vacuole traffic (Wichmann
et al., 1992; Schimmoller and Riezman, 1993). In this re-
port, we identify 16 sop mutants that permit pma1-7 to
grow at 378C. While in principle it seems possible to sup-
press temperature-sensitive growth of pma1-7 by altering
the physiological demand for proton pumping at the cell
surface, increased steady-state mutant Pma1 in sop mu-
tants suggests inhibition of vacuolar degradation (Fig. 2).
Therefore, allowing mutant Pma1 to escape vacuolar deg-
radation by moving to the cell surface is a major mecha-
nism of suppression (Fig. 3). Eight of the sop mutants are
also defective for vacuolar delivery of CPY; these vps mu-
tants have vacuolar morphologies belonging to class A and
E (Raymond et al., 1992). Five of the eight VPS genes
were previously cloned and sequenced. SOP selection re-
sulted in molecular identification and phenotypic charac-
terization of three VPS genes, VPS13, VPS38, and VPS36,
as well as six novel genes that regulate membrane traffic.
Figure 7. Steady-state Kex2 levels in sop mutants. Western blot
measuring steady-state level of Kex2p. Lysate (100 mg protein)
from wild-type (L3852) and sop mutants (strains listed in Fig. 6 B
legend) was resolved by SDS-PAGE and transferred to nitrocel-
lulose. Kex2p was detected by rabbit anti-Kex2 antibody fol-
lowed by 125Iprotein A and autoradiography. Bar graph shows
quantitation of Kex2 levels in sop mutants normalized to that of
wild-type (arrow) by densitometric scanning of the autoradio-
gram. Measurements are representative of two to four experi-
ments.
Figure 8. Sop2 is a member of the inositol 5-phosphatase family
and a homologue of synaptojanin. Alignment of Sop2 with rat
brain synaptojanin (gi1166575) and two yeast ORFs. OrfN2160
on chromosome XIV is available from GenBank/EMBL/DDBJ
under accession number Z50161. Orf P40559, a hypothetical
108.4-kD protein on chromosome IX, is in the SWISS-PROT
protein sequence database under accession number P40559. Pro-
tein sequences were aligned using the Megalign program
(DNAStar, Madison, WI). Identical amino residues are boxed,
and hyphens indicate gaps introduced to maximize alignment.
Asterisks indicate conserved motifs GDXN(Y/F)R and P(S/
A)W(C/T)DRIL that define inositol 5-phosphatases (Majerus,
1996). Sop2 is 31% identical with synaptojanin along its full
length.Luo and Chang Novel Genes Involved in Endosomal Traffic 743
The subset of sop mutants that is defective for vacuolar
protein sorting also reroutes a mutant Wbp1 fusion pro-
tein from the vacuole to the plasma membrane (Table III).
In sop cells, mutant Pma1 delivered to the plasma mem-
brane appears to remain stable at the surface (Fig. 3). (By
contrast, when an endogenous vacuolar membrane protein
is diverted to the plasma membrane, it quickly undergoes
endocytosis and moves to the vacuole [Nothwehr et al.,
1995].) It remains unknown, however, whether wild-type
Pma1 localization at the plasma membrane is maintained
by cycles of endocytosis and recycling back to the cell sur-
face.
Endosome-to-Vacuole Traffic Defects in a Subset of 
vps/sop Mutants
Our results underscore the interplay between protein traf-
ficking in the endocytic and biosynthetic pathways (Piper
et al., 1995; Singer-Kruger, 1995). Previously, three vps
mutants, vps34, vps2/ren1, and vps21/ypt51, have been
identified that display dual defects in endocytic and bio-
synthetic traffic to the vacuole (Davis et al., 1993; Munn
and Riezman, 1994; Singer-Kruger, 1995). Because indi-
rect immunofluorescence localization suggests mutant Pma1
traverses an endosomal compartment en route to the vac-
uole (Fig. 1), it was not unreasonable to hypothesize a de-
fect in the endocytic pathway in some sop mutants. In-
deed, the hypothesis is supported by endocytosis studies
using FM 4-64 (Fig. 5). The class E mutant vps36 accumu-
lates dye in a prevacuolar/endosomal compartment, seen
as a large spot adjacent to the vacuole, as described previ-
ously for vps27 and other class E mutants (Vida and Emr,
1995; Rieder et al., 1996). Interestingly, some class A vps/
sop mutants have characteristics in common with class E
mutants. In vps13 and vps38, we observed a delay in exit of
FM 4-64 from an endocytic intermediate compartment(s).
This compartment appears similar to the prevacuolar
compartment of class E vps cells, although it does not ap-
pear to have substantial proteolytic activity (Fig. 7). Inter-
estingly, vps13 (soi1) was recently found in a screen for
suppression of vacuolar mislocalization of a Kex2p mutant
with a defective trans-Golgi localization signal (Redding et
al., 1996). It is possible that in vps13 cells, there is reduced
vacuolar delivery of mutant Pma1 as well as the mutant
Kex2 as a consequence of a delay in traffic from endosome
to vacuole. Vacuolar delivery of FM 4-64 is also perturbed
in  vps8 because a fraction of the dye accumulates in a
novel endocytic intermediate that is seen as punctate cyto-
plasmic staining (see below).
Trafficking Defects between Endosome and Golgi in a 
Subset of sop Mutants
In class E vps mutants, retention of late Golgi membrane
proteins is defective, and Kex2 undergoes PEP4-depen-
dent degradation (Cereghino et al., 1995; Nothwehr et al.,
1996). In agreement with this observation, steady-state
Kex2 levels are diminished in vps27 and vps36 cells by
comparison with wild-type cells (Fig. 7). In several class A
vps/sop cells (mvp1, pep11, and vps35; Fig. 7), steady-state
Kex2p levels are also reduced, suggesting increased Kex2
degradation. Our findings are in contrast with a previous
suggestion that class A vps mutants are defective specifi-
cally in the soluble protein-sorting apparatus (Raymond et
al., 1992). In vps35 cells, secretion of unprocessed a factor
and reduction of steady-state Kex2 levels (Figs. 6 and 7)
are consistent with reports that Vps35 acts at the endo-
some to direct recycling of other late Golgi membrane
proteins from endosome to Golgi (Nothwehr et al., 1996;
Seaman et al., 1997).
In  vps8 cells, secretion of pro–a factor is slight, and
steady-state Kex2 levels are not significantly reduced
(Figs. 6 and 7). However, vps8 cells produce a strikingly
small halo (Fig. 6 A), suggesting a defect in mature a fac-
tor production that is as yet undefined. One possible ex-
planation for the small halo in vps8 is suggested by the ob-
servation that FM 4-64 accumulates in a structure
morphologically distinct from the class E prevacuolar com-
partment in vps8 (Fig. 5). Moreover, two different popula-
tions of endosomes (early and late) have been identified in
yeast, as in mammalian cells (Singer-Kruger et al., 1993;
Hicke et al., 1997). It is possible that in vps8 cells, there is a
mild defect in Kex2 localization but more substantial mis-
localization of the other trans-Golgi proteases, Kex1 and
Ste13 (which are necessary for generating mature, biologi-
cally active a factor [Fuller et al., 1988]).
Novel Non-vps sop Mutants
Selection of pma1 suppressors has resulted in the isolation
of six novel sop mutants. Of these, two sop mutants, sop2
and sop6, secrete unprocessed a factor and also display di-
minished steady-state Kex2 levels (Figs. 6 and 7). These
data suggest that these non-VPS SOP gene products also
participate in Kex2 trafficking and play a role in the endo-
somal/vacuolar pathway. While further work is necessary
to dissect the molecular mechanism of the SOP gene prod-
ucts (see below), it is of interest to our understanding of
endosomal protein trafficking that SOP2 encodes a homo-
logue of synaptojanin (Fig. 8). Synaptojanin, a nerve ter-
minus protein, has been proposed to regulate synaptic ves-
icle endocytosis and recycling (McPherson et al., 1996).
Sop2 and synaptojanin are members of the family of
IP5Pases that includes the protein defective in the oculo-
cerebrorenal syndrome of Lowe (Attree et al., 1992). Sop2
has closest similarity to the type II IP5Pases, which de-
phosphorylate inositol polyphosphates as well as phos-
phatidylinositol(4,5)diphosphate and phosphatidylinosi-
tol(3,4,5)triphosphate (De Camilli et al., 1996; Majerus,
1996). Enzymes involved in phosphatidylinositol metabo-
lism have been found to regulate many aspects of cell
physiology, including protein trafficking (Liscovitch and
Cantley, 1995; De Camilli et al., 1996). In yeast, such en-
zymes have been implicated in protein transport through
the Golgi (Skinner et al., 1993) and from Golgi to vacuole
(Stack et al., 1995). Our results suggest a role for Sop2 in
trafficking between endosome and Golgi.
Models for Entry of Mutant Pma1 into the
Endosomal/Vacuolar Pathway
At present, the molecular basis for entry of mutant Pma1
into the endosomal/vacuolar pathway is not understood.
One possible explanation for mislocalization of mutant
Pma1 is that a novel post-ER quality control mechanism
recognizes and directs mutant Pma1 to the endosomal/vac-The Journal of Cell Biology, Volume 138, 1997 744
uolar pathway. In this regard, it is clear that some proteins
continue to fold and assemble in post-ER compartments
(Wagner, 1990; Jascur et al., 1991; Huovila et al., 1992;
Musil and Goodenough, 1993). Moreover, it has been ob-
served that in both mammalian and yeast cells, some in-
completely assembled or misfolded proteins are targeted
for lysosomal degradation (without prior arrival at the
plasma membrane) (Minami et al., 1987; Armstrong et al.,
1990; Gaynor et al., 1994; Hong et al., 1996). Thus, the idea
that quality control is not an exclusive ER function is re-
ceiving increasing consideration (Hammond and Helenius,
1995).
An alternative explanation for mutant Pma1 mislocal-
ization is based on a proposal that, by contrast with mam-
malian cells, membrane protein traffic to the vacuole in
yeast occurs by “default,” i.e., membrane proteins without
sorting signals are delivered to the vacuole (Stack and
Emr, 1993; Nothwehr and Stevens, 1994). A corollary of
this hypothesis is that plasma membrane proteins have tar-
geting signals. According to this hypothesis, mutant Pma1
may have a defective plasma membrane targeting signal
that results in its vacuolar delivery by default. (If there is a
plasma membrane targeting machinery, we would not ex-
pect SOP genes to encode these components since sop
mutants were generated by insertional mutagenesis.)
Models for SOP Action
We have taken a first step towards understanding the
mechanism of vacuolar delivery of mutant Pma1 by identi-
fying SOP genes. Different trafficking defects seen in the
sop mutants suggest diverse means by which mutant Pma1
moves to the cell surface. We suggest that the sop mutants
fall into three classes depending on how vacuolar delivery
of mutant Pma1 is inhibited. One possible mode of sop ac-
tion is a direct one, in which a defect in the mechanism di-
recting mutant Pma1 into endosome-bound vesicles at the
Golgi results in transport of mutant Pma1 from Golgi to
surface. For example, this class of SOP genes may encode
constituents of a quality control mechanism that recognize
mutant proteins at the Golgi. Indeed, SOP3, SOP4, and
SOP5 may fall into this class. sop3, sop4, and sop5 mutants
suppress  pma1 without affecting CPY delivery (Fig. 4),
Kex2 recycling (Figs. 6 B and 7), or endocytic uptake of
FM 4-64 (not shown). SOP3, SOP4, and SOP5 encode
predicted transmembrane proteins, and Sop3 and Sop5
have similarity to mammalian receptors (Luo, W., and A.
Chang, unpublished result). These characteristics are con-
sistent with a possible “receptor” function for these pro-
teins.
Most of the sop mutants appear to fall into two addi-
tional classes that change traffic independently of the pri-
mary mislocalization event, resulting in cell surface deliv-
ery of mutant Pma1. Mutations in SOP genes of these two
classes may affect traffic at either the Golgi or an endo-
some compartment. For example, loss of proteins required
for formation of Golgi-to-endosome vesicles may slow exit
from the Golgi, and mutant Pma1 may escape to the sur-
face as a consequence. Mutants defective in endosome-
to-Golgi recycling may similarly suppress pma1 by slowing
exit from the Golgi since proteins required for formation
of Golgi-to-endosome vesicles have to recycle back. We
have placed the sop/vps mutants mvp1, pep11, vps35, the
class E mutants vps27 and vps36, and sop2 and sop6 in this
class because Kex2 trafficking between Golgi and endo-
some appears defective in these mutants (Fig. 7).
Diversion of mutant Pma1 to the cell surface after its ar-
rival in an endosomal compartment is another mechanism
of suppression. If there is a defect or delay in traffic from
endosomes to the vacuole, it is possible that newly synthe-
sized mutant Pma1 en route to the vacuole moves directly
from the endosome to the plasma membrane. vps13,
vps38, and vps8 are candidates for this subclass; these vps/
sop mutants are defective in endosome-to-vacuole traffic
(Fig. 5) but do not display severe trafficking defects be-
tween Golgi and endosome (Fig. 7). The class E vps mu-
tants display defects in trafficking in both pathways. Fur-
ther work is required to determine whether mutant Pma1
is diverted to the plasma membrane from the Golgi or af-
ter its entry into endosomes in vps27 and vps36 mutants. A
previous report that there is an increase in the cell surface
a factor receptor Ste3 in a class E vps mutant is consistent
with endosome-to-plasma membrane trafficking (Davis et
al., 1993). Although an endosome-to-surface traffic path-
way has not been described formally in yeast, such a pathway
has been established clearly in mammalian cells (Gruenberg
and Maxfield, 1995; De Camilli and Takei, 1996).
Disparate defects in the endosomal system in sop mu-
tants suggest that protein traffic to the cell surface may oc-
cur via multiple mechanisms. Future studies to dissect the
mechanisms of the SOP genes should aid in revealing
novel means to deliver proteins to the cell surface, as well
as further defining the endosomal system in molecular
terms.
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